Analyzing Ethema Health (OTCMKTS:GRST) and Oncology Institute (NASDAQ:TOI)

Ethema Health (OTCMKTS:GRST) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings for Ethema Health and Oncology Institute, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ethema Health	0	0	0	0	0.00
Oncology Institute	1	0	4	0	2.60

Oncology Institute has a consensus target price of $7.00, indicating a potential upside of 115.72%. Given Oncology Institute’s stronger consensus rating and higher probable upside, analysts clearly believe Oncology Institute is more favorable than Ethema Health.

Earnings & Valuation

This table compares Ethema Health and Oncology Institute”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ethema Health	$6.02 million	0.26	-$2.06 million	N/A	N/A
Oncology Institute	$502.73 million	0.64	-$60.61 million	($0.56)	-5.79

Ethema Health has higher earnings, but lower revenue than Oncology Institute.

Risk and Volatility

Ethema Health has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.17, indicating that its stock price is 83% less volatile than the S&P 500.

Insider and Institutional Ownership

36.9% of Oncology Institute shares are owned by institutional investors. 55.8% of Ethema Health shares are owned by insiders. Comparatively, 8.5% of Oncology Institute shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Ethema Health and Oncology Institute’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ethema Health	-9.35%	N/A	-5.77%
Oncology Institute	-11.45%	N/A	-33.70%

Summary

Oncology Institute beats Ethema Health on 6 of the 11 factors compared between the two stocks.

About Ethema Health

Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.

About Oncology Institute

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.